Guilin Sanjin Pharmaceutical Co Ltd

Guilin Sanjin Pharmaceutical Co Ltd maintains a strong liquidity position, with a current ratio of 3.01, indicating the company can cover its short-term liabilities more than three times over. However, the company has a negative net cash position after subtracting total debt, which introduces a medium liquidity risk. The company's debt-to-equity ratio is 0.16, suggesting a relatively conservative capital structure with limited leverage. In terms of profitability, the company's return on equity (ROE) is 13.57%, and its return on assets (ROA) is 10.17%, both of which are strong indicators of efficient use of equity and assets. These metrics suggest the company is generating solid returns relative to its capital base, though a direct comparison to industry medians is not available in the current dataset. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. This lack of diversification may expose the company to higher operational risk if demand for its primary product lines fluctuates. The geographic exposure is primarily within China, as no international revenue breakdown is disclosed. The company's growth trajectory is not explicitly outlined in the available data, but its operating cash flow of 708.12 million CNY and free cash flow of 104.48 million CNY suggest it has the capacity to fund operations and potentially reinvest in the business. However, capital expenditures are negative at -86.94 million CNY, indicating a reduction in investment in physical assets. The company's risk profile is characterized by a low dilution risk, with no significant dilution potential identified in the current data. However, the negative net cash position after subtracting total debt introduces a liquidity risk that should be monitored. No recent events, such as filings or transcripts, are available in the current dataset to provide additional context on the company's risk exposure. No recent events, such as filings or transcripts, are available in the current dataset to provide additional context on the company's operations or strategic direction.